President Trump insisted that Alex Azar would remain HHS secretary amid reports of his imminent firing; an analysis found that several nursing homes have mismanaged the threat of the coronavirus disease 2019 (COVID-19) in residents and staff; rural populations have been left stranded as several for-profit hospitals have closed amid the the COVID-19 pandemic.
An international team of investigators recently tried to answer this question, focusing on women with diagnosed early-stage disease and considered obese, with a body mass index above 30 kg/m2.
What relationship does the existence of comorbidities have on multiple sclerosis-related hospitalizations?
Site of care made a difference in chemotherapy costs.
Artificial intelligence and deep learning have advanced to the point where they can play a significant role in cancer care, but fully integrating the technology into the clinic remains a challenge.
High-flow nasal therapy (HFNT), often used for stable patients, can reduce hospital readmission for acute exacerbations for chronic obstructive pulmonary disease (COPD).
A new article outlining the experience of a patient with a history of multiple myeloma (MM) who contracted coronavirus disease 2019 (COVID-19) shows the interleukin-6 receptor inhibitor tocilizumab was an effective therapy.
A range of new research is helping scientists better understand psoriasis while also raising new questions. One approach is looking at how the gut microbiome affects the disease.
Patients with lymphoma have better odds of survival now than they did 20 years ago, according to new research. The data also help explain which types of cancer continue to be the most challenging.
Gathering the opinions of hospital pharmacists regarding the treatment of multiple sclerosis can be key for successful, multidisciplinary management of the disease, according to results from a focus group.
Despite significant burden and symptoms, many individuals with migraine have never used acute prescription pain medication to treat the condition, according to study results published in Mayo Clinic Proceedings.
Although the results have to be confirmed in a larger clinical trial, the researchers hope that the biomarker could be a noninvasive marker of a rare pediatric liver disease.
Patients who research medical information online are likely to be more concerned about switching from originator products to biosimilars, according to the study.
Chimeric antigen receptor (CAR) T-cell therapy has been shown to improve health-related quality of life in patients with relapsed/refractory diffuse large B-cell lymphoma (LBCL). Currently, CAR T-cell therapies are primarily administered in inpatient settings. In a study published in JAMA Network Open, researchers found CAR T-cell therapy administered to patients with relapsed or refractory LBCL in outpatient settings was associated with lower estimated overall costs.
Online systems, including telehealth, are imperative to maintaining optimal care for patients with multiple sclerosis (MS) during the coronavirus disease 2019 (COVID-19) pandemic, said June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers, in an interview with The American Journal of Managed Care® (AJMC®).
A number of advances have been made in recent years in our understanding of the genetics of psoriatic diseases and psoriatic arthritis specifically. However, those advances have yet to translate into clinically meaningful insights.
A new study based on treatment of patients with chronic lymphocytic leukemia (CLL) in mostly community settings challenges earlier findings about the superiority of a common therapeutic approach and also makes a strong case for ibrutinib.
Chronic obstructive pulmonary disease (COPD) is not an independent risk factor for metabolic disorders, according to a recent report.
In a set of updated guidelines issued for general neurologists managing patients with Parkinson disease (PD), researchers note the significance of efficient communication with members of a healthcare team specialized in movement disorders as they may assist in identifying and resolving common issues, especially among those with advanced PD.
A new survey found around 20% of cancer survivors are reluctant to switch jobs for fear of losing health insurance; the coronavirus disease 2019 (COVID-19) pandemic is disrupting anti-malaria campaigns in Africa; pregnant women and newborns may face pandemic complications at birth.
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
This week, the top managed care news included HHS' plans to allocate the remaining $70 billion in COVID-19 funding to providers; an analysis finding aggressive social distancing measures economically justified; highlights from this week's virtual Community Oncology Conference.
Following interim results presented at the 2017 Conference on Retroviruses and Opportunistic Infections, a team of investigators from Vall d’Hebron in Spain delivered their final results at this year’s virtual conference on cytomegalovirus (CMV) viral load response to antiretroviral therapy compared with anti-CMV treatment.
Compared with conventional methods, novel polysomnography parameters better describe how the severity of oxygen desaturation during sleep affects daytime alertness in patients with obstructive sleep apnea (OSA), according to study findings.
A new poll conducted by the Kaiser Family Foundation shows a majority of Americans fear the worst of the coronavirus disease 2019 (COVID-19) pandemic is yet to come; reports of blood clots in patients with COVID-19 raise concerns; Veterans' Affairs medical facilities are struggling to cope with the pandemic.
Implanting intraocular lenses (IOLs) after cataract surgery in infants is neither beneficial nor detrimental to long-term visual outcomes, according to a study published in JAMA Ophthalmology.
HHS will divide the remaining $70 billion of financial assistance included in the bipartisan CARES Act to providers and hospitals by 4 tranches, saying the money would also be used to provide care for the uninsured who are ill with coronavirus disease 2019.
In the United States, heart failure affects a patient population of over 6.5 million. Through medication management, transportation, and emotional support, among the many tasks they assist with, these patients’ caregivers provide services valued at $7.9 billion annually.
The FDA granted accelerated approval to Immunomedics’ Trodelvy (sacituzumab govitecan-hziy) as the first antibody-drug conjugate that targets the Trop-2 antigen. Trodelvy is indicated for treatment of relapsed or refractory metastatic triple-negative breast cancer (TNBC) that has spread to other parts of the body.
